Haolin Song

856 total citations
17 papers, 410 citations indexed

About

Haolin Song is a scholar working on Biomedical Engineering, Immunology and Molecular Biology. According to data from OpenAlex, Haolin Song has authored 17 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Biomedical Engineering, 6 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Haolin Song's work include Nanoplatforms for cancer theranostics (7 papers), Immune cells in cancer (5 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Haolin Song is often cited by papers focused on Nanoplatforms for cancer theranostics (7 papers), Immune cells in cancer (5 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Haolin Song collaborates with scholars based in China, South Korea and United States. Haolin Song's co-authors include Chen Jiang, Tao Sun, Hongyi Chen, Xuwen Li, Peixin Liu, Chufeng Li, Yifan Luo, Qinjun Chen, Zhenhao Zhao and Boyu Su and has published in prestigious journals such as Advanced Materials, Nano Letters and ACS Nano.

In The Last Decade

Haolin Song

16 papers receiving 404 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haolin Song China 7 158 153 97 61 53 17 410
Raquel Vinhas Portugal 11 158 1.0× 188 1.2× 124 1.3× 50 0.8× 53 1.0× 14 512
Yuqi Cao China 12 216 1.4× 145 0.9× 87 0.9× 79 1.3× 56 1.1× 21 424
Yueyang Deng China 8 140 0.9× 156 1.0× 101 1.0× 35 0.6× 42 0.8× 16 322
Xumei Ouyang China 10 190 1.2× 206 1.3× 104 1.1× 38 0.6× 65 1.2× 13 449
Collin T. Inglut United States 6 132 0.8× 160 1.0× 111 1.1× 35 0.6× 40 0.8× 9 371
Chunshun Jin China 12 70 0.4× 151 1.0× 69 0.7× 25 0.4× 32 0.6× 30 353
Junning Ma United States 9 201 1.3× 176 1.2× 164 1.7× 53 0.9× 46 0.9× 9 398
Neelesh Soman United States 9 69 0.4× 236 1.5× 79 0.8× 57 0.9× 45 0.8× 12 570
Qi Yin China 10 343 2.2× 236 1.5× 263 2.7× 105 1.7× 54 1.0× 14 556
Susana P. Egusquiaguirre Spain 9 113 0.7× 219 1.4× 164 1.7× 30 0.5× 21 0.4× 11 433

Countries citing papers authored by Haolin Song

Since Specialization
Citations

This map shows the geographic impact of Haolin Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haolin Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haolin Song more than expected).

Fields of papers citing papers by Haolin Song

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haolin Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haolin Song. The network helps show where Haolin Song may publish in the future.

Co-authorship network of co-authors of Haolin Song

This figure shows the co-authorship network connecting the top 25 collaborators of Haolin Song. A scholar is included among the top collaborators of Haolin Song based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haolin Song. Haolin Song is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Chen, Hongyi, Haolin Song, Chufeng Li, et al.. (2025). Cascade‐Targeted Nanoparticles for Enhanced Gemcitabine Delivery and Adenosine Metabolism Modulation to Overcome Treatment Resistance in Pancreatic Cancer. Advanced Science. 12(38). e07118–e07118. 2 indexed citations
3.
Zhang, Shilin, Haoyu You, Yun Chen, et al.. (2025). Transcytosis-Triggering Nanoparticles for Overcoming Stromal Barriers and Reversing Immunosuppression in Pancreatic Cancer Combinatorial Therapy. Nano Letters. 25(7). 2949–2959. 14 indexed citations
4.
Ouyang, Yulin, Zihao Chen, Qiang Huang, et al.. (2025). Modulation of Ryanodine Receptors on Microglial Ramification, Migration, and Phagocytosis in an Alzheimer’s Disease Mouse Model. Neuroscience Bulletin. 41(11). 2063–2077. 1 indexed citations
5.
Li, Xu‐Wen, Shuo Geng, Qinjun Chen, et al.. (2025). Disrupting Tumor Lactate Homeostasis to Sensitize Chemo-Immunotherapy Using a Glucose-Disguised Lactate Interceptor. ACS Nano. 19(23). 21556–21570.
6.
Su, Boyu, Qinjun Chen, Xu‐Wen Li, et al.. (2025). A Methionine Allocation Nanoregulator for the Suppression of Cancer Stem Cells and Support to the Immune Cells by Epigenetic Regulation. Advanced Science. 12(15). e2415207–e2415207. 1 indexed citations
7.
Zhang, Zeqiang, Lei Guo, Yu Zhang, et al.. (2025). Industrial application of multi-robot destructive disassembly line balancing under component non-disassemblability for multi-product scenarios. International Journal of Production Research. 63(18). 6801–6826. 3 indexed citations
8.
Guo, Lei, Zeqiang Zhang, Yu Zhang, Yan Li, & Haolin Song. (2024). Exploring engineering applications of two-sided partial destructive disassembly line balancing problem under electrical limiting and time-of-use pricing. Expert Systems with Applications. 262. 125573–125573. 4 indexed citations
9.
Song, Haolin, Hongyi Chen, Qinjun Chen, et al.. (2024). Size and Charge Dual‐Switchable Nanoparticles for Achieving Chemosensitization and Immune Infiltration against Pancreatic Ductal Adenocarcinoma. Advanced Functional Materials. 35(1). 2 indexed citations
10.
Li, Xuwen, Qin Guo, Qinjun Chen, et al.. (2024). Reconciling the Cooperative–Competitive Patterns among Tumor and Immune Cells for Triple‐Negative Breast Cancer Treatment Using Multimodule Nanocomplexes. Advanced Materials. 36(26). e2312219–e2312219. 16 indexed citations
11.
Wang, Yu, Qinjun Chen, Yifan Luo, et al.. (2024). Metabolic Nanoregulators Induce Ferroptosis and Change Metabolite Flow to Reverse Immunosuppressive Tumor Microenvironment. ACS Nano. 18(51). 34996–35012. 5 indexed citations
12.
Chen, Hongyi, Haolin Song, Yifan Luo, et al.. (2023). Transcytosis Mediated Deep Tumor Penetration for Enhanced Chemotherapy and Immune Activation of Pancreatic Cancer. Advanced Functional Materials. 33(28). 29 indexed citations
13.
Chen, Hongyi, Qin Guo, Yongchao Chu, et al.. (2022). Smart hypoxia-responsive transformable and charge-reversible nanoparticles for the deep penetration and tumor microenvironment modulation of pancreatic cancer. Biomaterials. 287. 121599–121599. 61 indexed citations
14.
Song, Haolin & Chen Jiang. (2022). Recent advances in targeted drug delivery for the treatment of pancreatic ductal adenocarcinoma. Expert Opinion on Drug Delivery. 19(3). 281–301. 2 indexed citations
15.
Wang, Yu, Qinjun Chen, Haolin Song, et al.. (2022). A Triple Therapeutic Strategy with Antiexosomal Iron Efflux for Enhanced Ferroptosis Therapy and Immunotherapy. Small. 18(41). e2201704–e2201704. 41 indexed citations
16.
Liu, Peixin, Tongyu Zhang, Qinjun Chen, et al.. (2021). Biomimetic Dendrimer–Peptide Conjugates for Early Multi‐Target Therapy of Alzheimer's Disease by Inflammatory Microenvironment Modulation. Advanced Materials. 33(26). e2100746–e2100746. 115 indexed citations
17.
Guo, Qin, Xuwen Li, Wenxi Zhou, et al.. (2021). Sequentially Triggered Bacterial Outer Membrane Vesicles for Macrophage Metabolism Modulation and Tumor Metastasis Suppression. ACS Nano. 15(8). 13826–13838. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026